Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Oktober 2018

Planlagt Fastgjort Låst Flyttet Genmab
4.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • bongobobB Offline
    bongobobB Offline
    bongobob
    wrote on sidst redigeret af
    #472

    Kun en overskrift: https://www.sciencedirect.com/science/article/pii/S0161589018304255?via%3Dihub

    1 Reply Last reply
    0
    • bongobobB Offline
      bongobobB Offline
      bongobob
      wrote on sidst redigeret af
      #473

      Hexamerization-enhanced CD37 and CD20 antibodies synergize in CDC to kill patient-derived CLL cells with unprecedented potency

      1 Reply Last reply
      0
      • bongobobB Offline
        bongobobB Offline
        bongobob
        wrote on sidst redigeret af
        #474

        DuoHexa CD37 i kombi med CD20. Vi får nok masser af denne type nyheder det næste år

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #475

          De skal være velkomne 🙂

          1 Reply Last reply
          0
          • O Offline
            O Offline
            OHW
            wrote on sidst redigeret af
            #476

            arhg...patienterne er nok ikke enige med dig!

            1 Reply Last reply
            0
            • D Offline
              D Offline
              Doc4
              wrote on sidst redigeret af
              #477

              9:05..However, resistance of cancer cells to CDC is a major problem.
              Two FDA-approved CD20 IgG1 mAbs, rituximab and ofatumumab,
              promote only ∼15 and 50% CDC, respectively, of B cells from
              patients with chronic lymphocytic leukemia (CLL)...we report that hexamerization-enhanced mAbs, specific for CD20
              or CD37, induced 95–99% CDC of CLL B cells at concentrations of
              10–16 g/mL in samples from 20 patients. CD37 mAbs without the
              E430G mutation did not mediate CDC...

              1 Reply Last reply
              0
              • D Offline
                D Offline
                Doc4
                wrote on sidst redigeret af
                #478

                ...High levels of killing of primary cancer cells are
                unprecedented and provide new opportunities for development of
                improved antibody therapies exploiting CDC, particularly in CLL.

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #479

                  Daratumumab in myeloma update: expanding indications, Niels van de Donk @ ESH - https://www.youtube.com/watch?v=66TVQeKcp38

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #480

                    Update on recent smoldering multiple myeloma trials, Maria-Victoria Mateos @ESH https://www.youtube.com/watch?v=sF_fmbhnc0s

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #481

                      CD38 antibodies under investigation for myeloma: isatuximab, MOR202 & TAK-079 https://www.youtube.com/watch?v=8-oiXhcegjw

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #482

                        Updated CASTOR analysis: daratumumab plus Vd for R/R myeloma https://www.youtube.com/watch?v=2dwYLNTA19s

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #483

                          Så fik vi median. pfs for Castor DVd: aproxx 2 years vs 7 mdr. for Vd og 26 mdr for 1. relaps DVd.

                          1 Reply Last reply
                          0
                          • M Offline
                            M Offline
                            mobbyduck1
                            wrote on sidst redigeret af
                            #484

                            ja det er imponerende

                            1 Reply Last reply
                            0
                            • M Offline
                              M Offline
                              mobbyduck1
                              wrote on sidst redigeret af
                              #485

                              og vi ved at Pollux er endnu bedre

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                mobbyduck1
                                wrote on sidst redigeret af
                                #486

                                og 43% CR i 1.Relaps er det også mere end fint

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #487

                                  42 % fik komplet respons efter 1. relaps. Førhen så man slet ikke CR i relapsed setting. Det var kun noget der forekom i 1. linje.

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #488

                                    43% - jeg hørte forkert 🙂

                                    1 Reply Last reply
                                    0
                                    • M Offline
                                      M Offline
                                      mobbyduck1
                                      wrote on sidst redigeret af
                                      #489

                                      sorry 43

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #490

                                        Tusinde tak for link Bulder. http://www.proinvestor.com/index.php?p=debat_1&postid=76324

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #491

                                          Det var nu E L. As usual, one could say. 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger